Drug Search Results

Lonidamine

Alternative Names: lonidamine
Latest Update: 2024-05-12
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Glycolysis Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Italy | Portugal

Approved Indications: None

Known Adverse Events: None

Company: Molecular Templates
Company Location: AUSTIN TX 78729
Company CEO: Eric E. Poma
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lonidamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Prostatic Hyperplasia

Trial	Phase	Trial Status	Disease	Primary Completion Date
2005-001073-94	P3	Active, not recruiting	Prostatic Hyperplasia	2007-06-07
TH-CR-202	P3	Terminated	Prostatic Hyperplasia	2006-12-01
TH-CR-203	P2	Terminated	Prostatic Hyperplasia	2006-08-01

Recent News Events

Date	Type	Title
05/12/2024	PubMed	H2S-Powered Nanomotors for Active Therapy of Tumors by Inducing Ferroptosis and Lactate-Pyruvate Axis Disorders.
05/05/2024	PubMed	Mitochondria-Targeted Nanoadjuvants Induced Multi-Functional Immune-Microenvironment Remodeling to Sensitize Tumor Radio-Immunotherapy.
04/12/2024	PubMed	Discovery of Small Molecule Glycolytic Stimulants for Enhanced ApoE Lipidation in Alzheimer's Disease Cell Model.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions